Breakthrough T1DTzield approved for children ages one and older in stage 2 T1DThe U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type …
Copyright MatchingDonors.com©️ 2025 All rights reserved.